Vidaza and pyrexia Patient Reports February 11, 2012

Vidaza Side Effects Report #4884890-4
Vidaza side effect was reported by a Health Professional from UNITED STATES on Jan 02, 2006. Male patient, 80 years of age, weighting 130.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain , cardio-respiratory arrest, diarrhoea, haemoglobin decreased, jaundice , neutropenia, pyrexia. Vidaza dosage: 60 MG(M2 (100 MG), SUBCUTANEOUS. During the same period patient was treated with ADVAIR DISKUS, LASIX, NORVASC, PLAVIX, PROTONIX, PREDNISONE, TOPROL, PRAVACHOL. Patient died on 10/31/2005.

Vidaza Side Effects Report #4786831-7
Vidaza side effect was reported by a Physician from UNITED STATES on Oct 03, 2005. Female patient, 70 years of age, weighting 191.0 lb, was diagnosed with myelodysplastic syndrome, sideroblastic anaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: injection site erythema, injection site oedema, injection site pruritus, injection site warmth, lethargy, malaise, pyrexia. Vidaza dosage: unknown. During the same period patient was treated with PROTONIX, AMBIEN, TOPROL, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #4996409-8
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Apr 21, 2006. Female patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abscess , blood alkaline phosphatase increased, bone marrow failure, conjunctival haemorrhage, eye swelling, infective myositis, pyrexia. Vidaza dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with GENTAMICIN. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5906773-0
Vidaza side effect was reported by a Physician from AUSTRALIA on Sept 19, 2008. Male patient, 65 years of age, weighting 167.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pyrexia, tenosynovitis, white blood cell count decreased. Vidaza dosage: (75 MG/M2) ,SUBCUTANEOUS. During the same period patient was treated with THALIDOMIDE, AMLODIPINE, GLIPIZIDE. Patient was hospitalized. Patient recovered.


Vidaza Side Effects Report #5422150-3
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Aug 03, 2007. Male patient, 55 years of age, weighting 149.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial flutter, chest x-ray abnormal, diarrhoea, disease recurrence, hypertension, hypotension, pyrexia, tachycardia. Vidaza dosage: 135 MG (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE, CIPROFLOXACIN, ACYCLOVIR, ALLOPURINOL, PENICILLIN V, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #4690972-2
Vidaza side effect was reported by a Physician from on May 26, 2005. Male patient, 51 years of age, weighting 144.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: leukocytoclastic vasculitis, pyrexia. Vidaza dosage: 75 MG/M2 (135 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #4696511-4
Vidaza side effect was reported by a Physician from on June 14, 2005. Male patient, 51 years of age, weighting 144.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain , leukocytoclastic vasculitis, pyrexia. Vidaza dosage: 75 MG/M2 (135 MG, DAILY X 7 DAYS) SUBCUTANEOUS. During the same period patient was treated with LEVOFLOXACIN. Patient was hospitalized. Patient recovered.